HIV protease inhibitor Darunavir ethanolate, Purity ≥98%

Cat. No.: X24-06-ZQ951

HIV protease inhibitor Darunavir ethanolate, Purity ≥98%

Synonym: 635728-49-3; HIV protease inhibitor; Prezista; TMC114

  • MDL: MFCD18251642
  • CAS Number: 635728-49-3
  • Compound CID: 23725083
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Darunavir ethanolate, soluble in DMSO and insoluble in ethanol and water, blocks the protease enzyme, essential for the maturation and replication of HIV, playing a key role in highly active antiretroviral therapy (HAART). It targets HIV protease.
Molecular Weight
593.74
Molecular Formula
C27H37N3O7S.C2H6O
Targets
HIV protease
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 91 mg/mL (153.26 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Darunavir ethanolate is an HIV protease inhibitor developed to treat resistant strains of HIV by blocking proteolytic activity necessary for viral maturation.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0